Breast Cancer

Fundamentals of Evidence-Based Disease Management

Autorzy:

I. Craig Henderson

Wydawca: OUP USA

ISBN: 9780199919987

Print on demand. This item has an extended shipping time. The typical delivery time is 4-8 weeks.

499,20 zł

449,28 zł Zniżka 49,92 zł Brutto

Najniższa cena w okresie 30 dni przed promocją: 449,28 zł

Ilość

Od 4 do 6 tygodni

Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis

modalities. The single most important fact about breast cancer is the great variation in its natural history and its responsiveness to therapy from one patient to another. The clinician must integrate an assessment of the patients likely course based on clinical and pathological staging and laboratory studies with objective evidence on the benefits of therapy. The primary aim of this book is to provide the clinician with the tools to do just that. Outcomes of clinical trials anddetails about commonly used drug regimens, drug dosage, and the expected side effects are summarized in generous tables and figures. Medical terminology has been defined and descriptions of the evolution in our thinking and understanding of the disease are often given to provide perspective in theinterpretation of evidence from current studies for busy clinicians and trainees alike.

Szczegóły produktu

Wydawca OUP USA

Indeks 86373

EAN13 9780199919987

ISBN 9780199919987

Opis

Rok wydania: 2015
Numer wydania: 1
Oprawa: miękka foliowana
Liczba stron: 256
Wymiary (mm): 156 x 235
Waga (g): 448

1. Epidemiology and Risk Factors for Breast Cancer; 2. Primary and Secondary Prevention of Breast Cancer; 3. Premalignant Changes and In Situ Carcinoma; 4. Natural History of Invasive Breast Cancer; 5. Histology of Breast Cancer; 6. Clinical and Pathological Staging; 7. Molecular Factors as Prognostic/Predictive Tools and Therapeutic Targets; 8. Diagnosis, Work-up, and Follow-up of Breast Cancer Patients; 9. Treatment of the Breast and Regional Lymph Nodes Surgery and Radiation Therapy; 10. Adjuvant Systemic Therapy; 11. Neoadjuvant Therapy and Locally-Advanced or Inflammatory Breast Cancer; 12. Management of Metastatic Disease;